Dr. Quiroz-Mercado is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
777 Bannock St
# MC7782
Denver, CO 80204Phone+1 303-436-6000Fax+1 720-425-0230
Education & Training
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Surgical Retina and Vitreous, 1983 - 1984
- University Auto De Tamaulipas, Fac De MedClass of 1976
Certifications & Licensure
- CO State Medical License 2008 - 2016
Clinical Trials
- POSTERIOR SUB-TENON'S Avastin Start of enrollment: 2008 Jun 01
- Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy Start of enrollment: 2006 Apr 01
Roles: Contact, Sub-Investigator
Publications & Presentations
PubMed
- Bispecific VEGF-A and Angiopoietin-2 Antagonist RO-101 Preclinical Efficacy in Model of Neovascular Eye Disease.Li Xu, Jessi R Prentice, Raul Velez-Montoya, Alina Sinha, Mark R Barakat
Ophthalmology Science. 2024-01-18 - 9 citationsTreatment ofBlepharitis: A Prospective, Randomized, Controlled, Double-Masked Clinical Trial Comparing Topical Lotilaner Ophthalmic Solution, 0.25% Eyedrops to Vehicle.Elizabeth Yeu, Mark Holdbrook, Stephanie N Baba, Juan Carlos Ceballos, Martha Massaro-Corredor
Ocular Immunology and Inflammation. 2023-10-01 - 24 citationsA phase II randomized trial to evaluate the long-term (12-week) efficacy and safety of OC-01 (varenicline solution) nasal spray for dry eye disease: The MYSTIC study.Hugo Quiroz-Mercado, Everardo Hernandez-Quintela, Kuei Hsun Chiu, Eugenia Henry, Jeffrey A Nau
The Ocular Surface. 2022-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: